Venue: European Parliament, Spinelli building, Room 5E3
Alojz Peterle MEP, European Parliament (confirmed)
Elisabetta Caselli, Researcher, University of Ferrara (confirmed)
Silvio Brusaferro, Researcher, University of Undine (confirmed)
Mariano Votta, Active Citizenship Network (confirmed)
European Commission, AMR Task Force - TBC
Additional MEP / NGO - TBC
MODERATOR
Brian Maguire, Journalist, EURACTIV
PROGRAMME
16:30 – 17:00 Registration
17:00 – 17:45 Opening Statements
17:45 – 18:00 Discussion and Q&A
18:00 – 19:00 Networking Reception
FOR MORE INFORMATION:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Fighting AMR In Europe's Hospitals
Every year, Europe loses 25,000 citizens to antimicrobial resistance (AMR) and healthcare-associated infections (HAIs). This tragedy is coupled with economic losses of €1.5 billion in the EU alone. European health authorities see AMR as public health emergency. Finance ministries see AMR as serious budget impact. But #AMR is a fixable problem.
JOIN US TO DISCOVER HOW! And... check-out www.copma.it and www.pchs.it/en
HAIs affect up to 15% of hospitalized patients – voters, taxpayers. Persistent pathogenic microbial contamination of hospital surfaces and antibiotic resistance are among the main causes. Traditional methods of sanitation have shown their limits in controlling pathogenic contamination, therefore effective prevention, as well as sustainable and effective alternatives are needed urgently, to save citizens lives and protect healthcare budgets.
A new, multi-center study carried out in Italy, with the support of COPMA, a leading Italian service company, involved five Italian universities and seven hospitals. Lasting 18 months, the research goal was to demonstrate the effectiveness of the innovative ‘PCHS Sanitation System’.
The system was created and developed by COPMA, to create a healthy environment with low and stable pathogenic microbial load, and to evaluate its impact on the onset of HAIs. The results, and potential public impact, are very important:
Reduction of antibiotic therapy costs by 76%
Reduction of the main antibiotic resistance genes, from 70% to 99.99%
Stable pathogen reduction from 70 to 96%
HAIs reduction of 52%
REGISTRATION
#EUevents
Powered by iCagenda